Ellinghams

Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion

Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion

Scroll to Top

Ellinghams